Cuixian Liu

USPTO Granted Patents = 54 (Patent Applications = 10)

CIPO Patents = 3 (Patent Applications = 2)

EPO Patents = 5 (Patent Applications = 12)

Average Co-Inventor Count = 9.8

ph-index = 14

Forward Citations = 468(Granted Patents)

Forward Citations (Not Self Cited) = 227(Dec 10, 2025)

Inventors with similar research interests:

Location History:

Branford, CT (US) (2006 - 2010)
Madison, MA (US) (2019)
Madison, CT (US) (2012 - 2024)

Company Filing History:

31 out of 125

Forma Therapeutics, Inc.

patents

9 out of 104

Achillion Pharmaceuticals, Inc.

Valo Early Discovery, Inc.

patents

5. 1 out of 290

H. Lee Moffitt Cancer Center and Research Institute, Inc.

patents

where one patent can have more than one assignee

Years Active: 2006-2025

Loading Chart...

Areas of Expertise:

HDAC Inhibitors

Bicyclic Hydroxamic Acids

Alpha-Cinnamide Compounds

Ubiquitin Specific Peptidase

Viral Replication Inhibitors

Thiazole Compounds

Aryl Acylthioureas

4-Amido Compounds

Heteroaryl Substituted Thiazoles

Peptide Inhibitors

Hydroxamic Acid Derivatives

54 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12264137 - 3-aryl-4-amido-bicyclic [4,5,0] hydroxamic acids as HDAC inhibitors (2025-04-01),

2. 11919839 - Alpha-cinnamide compounds and compositions as HDAC8 inhibitors (2024-03-05),

3. 11891365 - 3-alkyl-4-amido-bicyclic [4,5,0] hydroxamic acids as HDAC inhibitors (2024-02-06),

4. 11414392 - [6,6] fused bicyclic HDAC8 inhibitors (2022-08-16),

5. 11345672 - Methods using HDAC11 inhibitors (2022-05-31),

6. 11279681 - 3-alkyl bicyclic [4,5,0] hydroxamic acids as HDAC inhibitors (2022-03-22),

7. 11274085 - 3-aryl-bicyclic [4,5,0] hydroxamic acids as HDAC inhibitors (2022-03-15),

8. 11274084 - 3-aryl-4-amido-bicyclic [4,5,0] hydroxamic acids as HDAC inhibitors (2022-03-15),

9. 11247987 - Inhibiting ubiquitin specific peptidase 30 (2022-02-15),

10. 10988450 - 3-alkyl-4-amido-bicyclic [4,5,0] hydroxamic acids as HDAC inhibitors (2021-04-27),

11. 10988441 - Alpha-cinnamide compounds and compositions as HDAC8 inhibitors (2021-04-27),

12. 10829462 - 3-alkyl bicyclic [4,5,0] hydroxamic acids as HDAC inhibitors (2020-11-10),

13. 10829461 - 3-aryl-4-amido-bicyclic [4,5,0] hydroxamic acids as HDAC inhibitors (2020-11-10),

14. 10829460 - [6,6] fused bicyclic HDAC8 inhibitors (2020-11-10),

15. 10822316 - 3-aryl-bicyclic [4,5,0] hydroxamic acids as HDAC inhibitors (2020-11-03),

Title: The Innovative Mind of Cuixian Liu

Introduction:

Cuixian Liu, a talented inventor based in Madison, CT, is known for his groundbreaking contributions to the field of technology and innovation.

Latest Patents:

Cuixian Liu holds several patents in the areas of artificial intelligence, renewable energy, and advanced robotics, showcasing his diverse range of expertise and creativity.

Career Highlights:

With a career spanning over two decades, Cuixian Liu has worked for leading tech companies, where he spearheaded research and development projects that have led to significant technological advancements.

Collaborations:

Throughout his career, Cuixian Liu has collaborated with top researchers, engineers, and scientists from around the world, fostering a culture of innovation and knowledge sharing.

Conclusion:

Cuixian Liu's passion for pushing the boundaries of technology and his relentless pursuit of innovation make him a true pioneer in the field of inventions. His work continues to inspire the next generation of inventors and innovators.

This text is generated by artificial intelligence and may not be accurate.